Knowledge, attitudes, and behaviors of youths in the US hemophilia population: Results of a national survey

American Journal of Public Health

Volumn 96, Issue 9, 2006, Pages 1618-1622

  Nazzaro, Ann Marie ^a   Owens, Sally ^b   Hoots, W Keith ^c   Larson, Kelly L ^d  

^a National Hemophilia Foundation   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Gulf States Hemophilia and Thrombophilia Center   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTHROPATHY; ARTICLE; ATTITUDE TO ILLNESS; EXERCISE; HEALTH BELIEF; HEALTH PROMOTION; HEALTH SURVEY; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; ILLNESS BEHAVIOR; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHYSICAL ACTIVITY; QUESTIONNAIRE; RANDOMIZATION; RISK FACTOR; TELEPHONE;

ADOLESCENT; ADULT; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HEMOPHILIA A; HEPATITIS B; HEPATITIS C; HUMANS; JOINT DISEASES; MALE; UNITED STATES;

EID: 33748047802     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2005.075234     Document Type: Article

References (16)

1. Soucie JM, Evatt B, Jackson D. Hemophilia Surveillance System Project Investigators. Occurrence of hemophilia in the United States. Am J Hematol. 1998;59:288-294.
2. DiPaola J, Nugent D, Young G. Current therapy for rare factor deficiencies. Haemophilia. 2001;7(suppl): 16-22.
3. Hemophilia Data Set, Calendar Year 2000. Atlanta, Ga: Centers for Disease Control and Prevention; 2000.
4. Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relationship with source of medical care. Blood. 2000;96:437-442.
5. Battistella LR. Maintenance of musculoskeletal function in people with haemophilia. Haemophilia. 1998;4(suppl 2):26-32.
6. Rodriguez-Merchan EC. Effects of hemophilia on articulations of children and adults. Clin Orthop. 1996;328:7-13.
7. Recommendation Concerning Prophylaxis. New York, NY: National Hemophilia Foundation, Medical and Scientific Advisory Council; 2001. MASAC document 117, updated June 2006, document 170.
8. Report on the Universal Data Collection Program. Atlanta, Ga: Centers for Disease Control and Prevention; 2005.
9. Manco-Johnson MJ, Abshire TC, Brown D, et al. Initial results of a randomized, prospective trial of prophylaxis to prevent joint disease in young children with factor VIII (FVIII) deficiency. Paper presented at Annual Meeting of the American Society of Hematology, December 2005, Atlanta, Ga.
10. Chorba T, Holman R, Clarke M, Evatt B. Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States. Am J Hematol. 2001;66:229-240.
11. Eyster E, Sherman KE, Goedert JJ, et al. Prevalence and changes in hepatitis C virus genotypes among multi-transfused persons with hemophilia. J Infect Dis. 1999;179:1062-1069.
12. Ragni MV. Hepatitis A vaccine trial in individuals with hemophilia. HemAware. January/February 1997: 14-16.
13. Kyngäs H, Kroll T, Duffy M. Compliance in adolescents with chronic diseases: a review. J Adolesc Health. 2000;26:379-388.
14. International Physical Activity Questionnaire. Available at: http://www.ipaq.ki.se. Accessed June 15, 2006 (originally accessed Spring 1998).
15. Soucie JM, Richardson LC, Evatt B, et al. Risk factors for infection with hepatitis B and hepatitis C viruses in a large cohort of hemophilic males. Transfusion. 2001;41:338-343.
16. Green K. Treatment strategies for adolescents with hemophilia: opportunities to enhance development Adolesc Med. 1999;10:369-376.